These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 6303353

  • 1. Inhibition of lymphocyte function by 9-deazaadenosine.
    Zimmerman TP, Deeprose RD, Wolberg G, Stopford CR, Duncan GS, Miller WH, Miller RL, Lim MI, Ren WY, Klein RS.
    Biochem Pharmacol; 1983 Apr 01; 32(7):1211-7. PubMed ID: 6303353
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of lymphocyte-mediated cytolysis by 3-deazaadenosine: evidence for a methylation reaction essential to cytolysis.
    Zimmerman TP, Wolberg G, Duncan GS.
    Proc Natl Acad Sci U S A; 1978 Dec 01; 75(12):6220-4. PubMed ID: 216017
    [Abstract] [Full Text] [Related]

  • 3. Effects of adenosine deaminase inhibitors on lymphocyte-mediated cytolysis.
    Wolberg G, Zimmerman TP.
    Ann N Y Acad Sci; 1985 Dec 01; 451():215-26. PubMed ID: 3878118
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of lymphocyte-mediated cytolysis and cyclic AMP phosphodiesterase by erythro-9-(2-hydroxy-3-nonyl)adenine.
    Duncan GS, Wolberg G, Schmitges CJ, Deeprose RD, Zimmerman TP.
    J Immunopharmacol; 1982 Dec 01; 4(1-2):79-100. PubMed ID: 6296234
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Alterations in nucleotide pools induced by 3-deazaadenosine and related compounds. Role of adenylate deaminase.
    Bennett LL, Brockman RW, Allan PW, Rose LM, Shaddix SC.
    Biochem Pharmacol; 1988 Apr 01; 37(7):1233-44. PubMed ID: 3355597
    [Abstract] [Full Text] [Related]

  • 8. 3-Deazaadenosine. S-adenosylhomocysteine hydrolase-independent mechanism of action in mouse lymphocytes.
    Zimmerman TP, Iannone M, Wolberg G.
    J Biol Chem; 1984 Jan 25; 259(2):1122-6. PubMed ID: 6693378
    [Abstract] [Full Text] [Related]

  • 9. Effects of calmodulin antagonists on immune mouse lymphocytes.
    Wolberg G, Zimmerman TP.
    Mol Pharmacol; 1984 Sep 25; 26(2):286-92. PubMed ID: 6482875
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. S-adenosylhomocysteine hydrolase activity, deoxyadenosine triphosphate accumulation, and competence of thymocyte and spleen leucocyte response to mitogens in coformycin-treated mice.
    Lukey T, Snyder FF.
    Biochem Pharmacol; 1983 Apr 15; 32(8):1399-406. PubMed ID: 6860359
    [Abstract] [Full Text] [Related]

  • 12. 3-Deazaadenosine 5'-triphosphate: a novel metabolite of 3-deazaadenosine in mouse leukocytes.
    Prus KL, Wolberg G, Keller PM, Fyfe JA, Stopford CR, Zimmerman TP.
    Biochem Pharmacol; 1989 Feb 01; 38(3):509-17. PubMed ID: 2537081
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycin.
    Cass CE, Selner M, Tan TH, Muhs WH, Robins MJ.
    Cancer Treat Rep; 1982 Feb 01; 66(2):317-26. PubMed ID: 6976834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.